Nebenwirkungen · Rekovelle
REKOVELLE 12 micrograms/0.36 mL solution for injection in a pre-filled pen REKOVELLE 36 micrograms/1.08 mL solution for injection in a pre-filled pen REKOVELLE 72 micrograms/2.16 mL solution for injection in a pre-filled pen · Abschnitt 4.8 · PDF-Seite 7
HOS-133540 · Präparat HOS-097448
Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-06-29T09:34:00Z · SHA-256 bdc5f0d06704b7d96e66afefad4d2988deecb2ea531ba676d522ec5bf561ded0 · Passage 42f7144177697b690f59b1bda795c3fd216297691cf296a2e1269a137feab3cd · Zeichen 2319–2674 im Abschnitt